Labcorp Files 8-K on Operations and Financials
Ticker: LH · Form: 8-K · Filed: Apr 25, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-reporting
TL;DR
Labcorp dropped an 8-K on April 25th detailing financial results and condition.
AI Summary
Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on April 25, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing is a standard regulatory disclosure for Laboratory Corporation of America Holdings, informing investors and the public about the company's financial performance and operational status.
Risk Assessment
Risk Level: low — This filing is a routine regulatory disclosure and does not contain new material information that would inherently increase risk.
Key Players & Entities
- Laboratory Corporation of America Holdings (company) — Registrant
- Labcorp (company) — Commonly known name for the Registrant
- 0000920148-24-000029 (document_id) — Accession Number for the filing
- April 25, 2024 (date) — Date of filing and earliest event reported
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The provided text of the 8-K filing does not contain specific financial figures or detailed results of operations. It only indicates that the filing is for 'Results of Operations and Financial Condition'.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on April 25, 2024.
What is the primary purpose of this 8-K filing for Laboratory Corporation of America Holdings?
The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits as required by the SEC.
Where are Laboratory Corporation of America Holdings' principal executive offices located?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the SEC Act under which this 8-K is filed?
This 8-K filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 379 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2024-04-25 07:04:59
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240425.htm (8-K) — 24KB
- form8-kerex991forq12024.htm (EX-99.1) — 273KB
- labcorp_logoxhorizontalxcoa.jpg (GRAPHIC) — 108KB
- 0000920148-24-000029.txt ( ) — 585KB
- lh-20240425.xsd (EX-101.SCH) — 2KB
- lh-20240425_lab.xml (EX-101.LAB) — 22KB
- lh-20240425_pre.xml (EX-101.PRE) — 13KB
- lh-20240425_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated April 25, 2024 issued by Labcorp titled "Labcorp Announces 2024 First Quarter Results"
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary April 25, 2024